At Abyntek Biopharma, driven by our commitment to excellence in providing research reagents, we launched Abyntek Research Reagents, a range of high-quality bioreagents for oncological research, including over 46,000 references of antibodies, proteins, and ELISA/CLIA kits for the study of hundreds of biomarkers across various types of cancer.

After more than 15 years of leadership in supplying antibodies and other biological products, we embarked on this new challenge with the goal of providing the scientific community with top-tier reagents for oncological research, backed by the technical expertise of our scientific team and held to the highest quality standards.

We have focused on obtaining sensitive and specific tools that enable the scientific community to carry out their oncological research projects with greater efficiency, facilitating the rapid, robust, and reproducible results they need.

“Abyntek Research Reagents was created with a dual purpose. On one hand, to provide the scientific community with a wide range of quality bioreagents for cancer research, and on the other, to contribute to breast cancer research by dedicating a portion of the profits to this cause.”

But beyond our commitment to quality for our clients and researchers, we want our work to go further and have a meaningful social impact. This is why, at Abyntek, we have decided to allocate a portion of the revenue from the Abyntek Research Reagents line to breast cancer research projects, either through donations to research groups or associations working in this field, or by launching our own R&D initiatives in this area.